Cargando…

Host directed therapies: COVID-19 and beyond

The global spread of SARS-CoV-2 has necessitated the development of novel, safe and effective therapeutic agents against this virus to stop the pandemic, however the development of novel antivirals may take years, hence, the best alternative available, is to repurpose the existing antiviral drugs wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tripathi, Devavrat, Sodani, Megha, Gupta, Pramod Kumar, Kulkarni, Savita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	COVID-19 therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464038/ https://www.ncbi.nlm.nih.gov/pubmed/34870156 http://dx.doi.org/10.1016/j.crphar.2021.100058

Ejemplares similares

A research update: Significance of cytokine storm and diaphragm in COVID-19
por: Mittal, Ashwani, et al.
Publicado: (2021)

Hypoxia may be a determinative factor in COVID-19 progression
por: Grieb, Pawel, et al.
Publicado: (2021)

Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19
por: Rabie, Amgad M.
Publicado: (2021)

Can NLRP3 inhibitors improve on dexamethasone for the treatment of COVID-19?
por: Hooftman, Alexander, et al.
Publicado: (2021)

Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2021)

Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19
por: Neta, Francisca Idalina, et al.
Publicado: (2021)

Can the application of graphene oxide contribute to the fight against COVID-19? Antiviral activity, diagnosis and prevention
por: Rhazouani, Asmaa, et al.
Publicado: (2021)

Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL(pro) and M(pro)/ 3CL(pro): molecular docking and simulation studies of three pertinent medicinal plant natural components
por: Verma, Devvret, et al.
Publicado: (2021)

Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2
por: Prasad, Kartikay, et al.
Publicado: (2021)

Challenges and Opportunities of Preclinical Medical Education: COVID-19 Crisis and Beyond
por: Gaur, Uma, et al.
Publicado: (2020)

New-onset anosmia and taste distortion: see beyond COVID-19
por: Casciato, Sara, et al.
Publicado: (2020)

Immune health grades: Finding resilience in the COVID-19 pandemic and beyond
por: Marconi, Vincent C., et al.
Publicado: (2022)

Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2
por: Bajad, Nilesh Gajanan, et al.
Publicado: (2021)

The Inanimate Third: Going Beyond Psychodynamic Approaches for Remote Psychotherapy during the COVID‐19 Pandemic
por: Ferber, Sari Goldstein, et al.
Publicado: (2022)

Neuromuscular presentations in patients with COVID-19
por: Paliwal, Vimal Kumar, et al.
Publicado: (2020)

Recent progress in the development of potential drugs against SARS-CoV-2
por: Chen, Jianmin, et al.
Publicado: (2021)

The development of biologics to target SARS-CoV2: Treatment potential of antibodies in patient groups with poor immune response
por: Migo, William, et al.
Publicado: (2021)

Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside
por: Tao, Sijia, et al.
Publicado: (2021)

COVID-19 infection and Down syndrome—challenges and future directions for care in children
por: Chauhan, Kaushambi, et al.
Publicado: (2022)

A Theme Series on Emerging Technologies for Use in the Study, Diagnosis and Treatment of Patients with COVID-19
por: Simmons, Chelsey S., et al.
Publicado: (2020)

COVID-19 and its Modes of Transmission
por: Karia, Rutu, et al.
Publicado: (2020)

Neurological manifestations of COVID-19 in patients: from path physiology to therapy
por: Merino, J. J., et al.
Publicado: (2021)

Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
por: Pourahmad, Ramtin, et al.
Publicado: (2020)

Global sharing of COVID‐19 therapies during a “New Normal”
por: Jecker, Nancy S., et al.
Publicado: (2022)

Monoclonal antibody therapy for prevention of severe disease in nosocomial COVID-19
por: Zimilover, Adam, et al.
Publicado: (2022)

Beyond Duty: Medical “Heroes” and the COVID-19 Pandemic
por: Lipworth, Wendy
Publicado: (2020)

Neurological manifestations and comorbidity associated with COVID-19: an overview
por: Kumar, Mukesh, et al.
Publicado: (2020)

Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19
por: Leeson, Cale E., et al.
Publicado: (2020)

Neurological music therapy during the COVID-19 outbreak: updates and future challenges
por: Vinciguerra, Claudia, et al.
Publicado: (2022)

Spectrum of neurological complications following COVID-19 vaccination
por: Garg, Ravindra Kumar, et al.
Publicado: (2021)

The interrelation of COVID-19 and neurological modalities
por: Jakhmola, Shweta, et al.
Publicado: (2021)

Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer’s disease populations
por: Iodice, Francesco, et al.
Publicado: (2021)

Neurological toll of COVID-19
por: Bhola, Shivam, et al.
Publicado: (2022)

COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy
por: Vitiello, Antonio, et al.
Publicado: (2020)

Cerebral Venous Thrombosis in Acute Lymphoblastic Leukemia with Severe COVID-19: a Case Report
por: Manral, Ishita, et al.
Publicado: (2021)

Reassessing IVIg therapy in chronic inflammatory demyelinating polyradiculoneuropathy during COVID-19: a chance to verify the need for chronic maintenance therapy
por: Romozzi, Marina, et al.
Publicado: (2021)

Impact of COVID-19 on post-graduate orthopaedic training in Delhi-NCR
por: Upadhyaya, Gaurav Kumar, et al.
Publicado: (2020)

Advancing Global Health Equity in the COVID-19 Response: Beyond Solidarity
por: Johnson, Stephanie B.
Publicado: (2020)

Beyond Traditional Advance Care Planning: Tailored Preparedness for COVID-19
por: Cavalier, Joanna S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r241o4cn101481d1i27ff36pm6